Complete the form below for more information about our latest product

Our latest product is designed for easier isolation and activation of T cells for human therapies! We are offering you early access to the Soluble DynActivator CD3/CD28 Prototype Reagent for its potential to be valuable in your current and upcoming therapy development projects.

Soluble DynActivator CD3/CD28 Prototype Reagent offers:

• Process flexibility to activate cells separate from the isolation step
• Ability to use high cell count as starting material
• An alternative to current activation options

(*Indicates a mandatory field)

First name *

Last name *

Job title

Phone

Email *

Company / institution *

City *

Zip / postal code *

Country / region *

Please selectAfghanistanAland IslandsAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaireBosnia & HerzegovinaBotswanaBouvet IslandBrasilBritish Indian OceanBritish Virgin IslandsBruneiBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCape VerdeCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos IslandsColumbiaComorosCongoCook IslandsCosta RicaCôte D'IvoireCroatiaCuracaoCyprusCzech RepublicDemocratic Republic of CongoDenmarkDjiboutiDominicaDominican RepublicTIMOR-LESTEEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFalkland IslandsFaroe IslandsFederated States of MicronesiaFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuianaGuineaGuinea - BissauHaitiHeard Island and McDonald IslandsHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKosovoKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxemburgMacauMacedoniaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew Zealand (Aotearoa)NicaraguaNigerNigeriaNiueNorfolk IslandNorwayOmanPakistanPalauPalestinePanamaPapua New GuineaParaguayPeruPhilipinesPitcairn IslandsPolandPortugalPuerto RicoQatarRéunionRomaniaRussiaRwandaSaint HelenaSaint Kitts and NevisSaint LuciaSaint Pierre and MiquelonSaint Vincent and the GrenadinesSan MarinoSão Tomé and PríncipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSaint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSamoaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth KoreaSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwedenSwitzerlandSyriaTaiwanTajikistanTanzaniaThailandTogoTokelauTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos IslandsTuvaluUgandaUnited KingdomUkraineUnited Arab EmiratesUnited StatesUnited States Minor Outlying IslandsUruguayUzbekistanVanuatuVatican CityVenezuelaViet NamVirgin IslandsWallis and FutunaWestern SaharaYemenZambiaZimbabwe

Please enter any specific questions you have.

I acknowledge that this product is a prototype, and its performance characteristics have not been established. This product is currently undergoing validation, including real‑time stability and shelf‑life studies. Any questions or concerns about product performance will be routed directly to the R&D team. The product may be subject to changes in the final manufacturing environment and processes.*

Yes, I wish to receive communication via telephone, email, or other electronic means on Thermo Fisher Scientific goods and services.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Submit

By submitting this form, I confirm that I understand and agree to the pre‑commercial product terms and conditions below.

Pre-Commercial Product Terms and Services:
Gibco Soluble DynActivator CD3/CD28 Prototype (the “Use at Risk Product”) is not yet a commercially released product and is still under development. Any use of the Use at Risk Product is done at the sole risk and discretion of Customer. Additionally, the Customer understands and agrees that the Use at Risk Product is provided 'AS IS' and without warranty of any kind, express, implied or statutory. All warranties are expressly disclaimed, including, without limitation, those of merchantability or fitness for a particular purpose, and non‑infringement of third‑party intellectual property rights, whether arising from statute or in law or from a course of dealing or usage of trade. Thermo Fisher disclaims all responsibility or liability for Customer's use of the Use at Risk Product (or any portion thereof), including, but not limited to, any liability or responsibility under Thermo Fisher's standard terms of sale, a negotiated master supply agreement, or a quality agreement. The Use at Risk Product is provided under Thermo Fisher's standard terms and conditions located at www.thermofisher.com/bpd-tcs except as specifically modified by the above.